SPACE HEALTH & MEDICINE ON AUSTRALIA’S CLINICAL LAUNCHPAD
With
Professor Tracy Smart AO, Air Vice-Marshal (Ret’d)
BMBS, MPH, MA, Dip AvMed, FRACMA, FACAsM, FAsMA, FCDSS, FACHSM (Hon) &
Tracy Smart AO, Professor, Military and Aerospace Medicine
The Australian National University
HEALTH EXECUTIVE INSIGHTS SEGMENT
Filmed in Canberra | April 2026
Professor Smart is a veteran, medical doctor, health leader, aerospace medicine specialist, and retired Royal Australian Air Force (RAAF) senior officer. She is currently at the Professor, Military and Aerospace Medicine at the Australian National University (ANU), and serves as the Interim Director of the ANU Defence Institute, and as a Mission Specialist at the ANU Institute for Space. She previously served as the University’s COVID-19 Public Health Lead from 2020 to 2022.
Prof Smart’s 35-year RAAF career included several operational deployments, and leadership and command positions at the tactical, operational, and strategic levels of Defence. Her career culminated in the roles of Surgeon General of the ADF and Commander Joint Health. In these roles she drove substantial reform in the delivery of policy, programs, and treatment in the military Mental Health space, and in the health aspects of transition from Defence. She transferred to the RAAF Specialist Reserve in early 2020 and continues to take a strong interest in Defence and Veterans’ health.
Apart from her ANU roles, Prof Smart is a non-executive Director of Goodwin Aged Care Services and the International Academy of Air and Space Medicine; Chair of the ANZAC Research Institute and the Australian Football League Industry Mental Health Steering Group; and Co-Chair of the Australian War Memorial Gallery Development Project Veterans’ Advisory Group. She is a member of the Defence Honours and Awards Appeals Tribunal, an Honorary (Professorial Fellow) in the Psychiatry Department, University of Melbourne, a frequent keynote speaker, and undertakes various consulting and advisory roles in aerospace medicine and military and veterans’ health.
Source: Supplied
https://orcid.org/0009-0005-8918-8939
-
Misinformation impacts routine vaccines
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
Recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
